儿童变应性鼻炎患者新型冠状病毒疫苗接种专家共识

2021-11-26 复旦大学附属眼耳鼻喉科医院耳鼻喉科变态反应中心中国耳鼻咽喉颅底外科杂志

面对新型冠状病毒(简称新冠病毒)疫情世界范围内大流行的严峻局面,全社会接种疫苗构建完整的免疫屏障已经成为抗击疫情最经济、最有效的手段之一。截至2021年11月初,全国各地累计报告接种新冠病毒疫苗23亿

中文标题：

发布机构：

复旦大学附属眼耳鼻喉科医院耳鼻喉科变态反应中心

发布日期：

2021-11-26

简要介绍：

面对新型冠状病毒(简称新冠病毒)疫情世界范围内大流行的严峻局面,全社会接种疫苗构建完整的免疫屏障已经成为抗击疫情最经济、最有效的手段之一。截至2021年11月初,全国各地累计报告接种新冠病毒疫苗23亿剂次。近来全国多地已经陆续开始为3～11岁的儿童接种新冠疫苗。变应性鼻炎(AR)是一种常见的儿童呼吸道慢性炎症性病变,需要鼻喷或口服抗过敏药(抗组胺药和糖皮质激素等)进行对症治疗,和/或进行变应原特异性免疫治疗(AIT)建立免疫耐受。为了顺利推进和实施新冠病毒疫苗在AR儿童的接种工作,东方过敏联盟牵头组织了国内知名的耳鼻咽喉科、变态反应科和儿科专家,在系统复习国内外文献证据的基础上,结合专家的临床经验制订了本共识,旨在指导儿童AR患者,特别是接受AIT的患者,进行安全有效的新冠疫苗接种,构建群体免疫的屏障。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=ab8481c00228030b, title=儿童变应性鼻炎患者新型冠状病毒疫苗接种专家共识, enTitle=, guiderFrom=中国耳鼻咽喉颅底外科杂志, authorId=0, author=, summary=面对新型冠状病毒(简称新冠病毒)疫情世界范围内大流行的严峻局面,全社会接种疫苗构建完整的免疫屏障已经成为抗击疫情最经济、最有效的手段之一。截至2021年11月初,全国各地累计报告接种新冠病毒疫苗23亿, cover=https://img.medsci.cn/20211130/1638257359207_5579292.jpg, journalId=0, articlesId=null, associationId=2193, associationName=复旦大学附属眼耳鼻喉科医院耳鼻喉科变态反应中心, associationIntro=复旦大学附属眼耳鼻喉科医院耳鼻喉科变态反应中心, copyright=0, guiderPublishedTime=Fri Nov 26 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">面对新型冠状病毒(简称新冠病毒)疫情世界范围内大流行的严峻局面,全社会接种疫苗构建完整的免疫屏障已经成为抗击疫情最经济、最有效的手段之一。截至2021年11月初,全国各地累计报告接种新冠病毒疫苗23亿剂次。近来全国多地已经陆续开始为3～11岁的儿童接种新冠疫苗。变应性鼻炎(AR)是一种常见的儿童呼吸道慢性炎症性病变,需要鼻喷或口服抗过敏药(抗组胺药和糖皮质激素等)进行对症治疗,和/或进行变应原特异性免疫治疗(AIT)建立免疫耐受。为了顺利推进和实施新冠病毒疫苗在AR儿童的接种工作,东方过敏联盟牵头组织了国内知名的耳鼻咽喉科、变态反应科和儿科专家,在系统复习国内外文献证据的基础上,结合专家的临床经验制订了本共识,旨在指导儿童AR患者,特别是接受AIT的患者,进行安全有效的新冠疫苗接种,构建群体免疫的屏障。 </span></p>, tagList=[TagDto(tagId=27739, tagName=变应性鼻炎)], categoryList=[CategoryDto(categoryId=30, categoryName=耳鼻咽喉, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=27739, guiderKeyword=变应性鼻炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2066, appHits=86, showAppHits=0, pcHits=437, showPcHits=1980, likes=1, shares=8, comments=11, approvalStatus=1, publishedTime=Tue Nov 30 15:34:03 CST 2021, publishedTimeString=2021-11-26, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Nov 30 15:33:19 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 17:21:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=_儿童变应性鼻炎患者新型冠状病毒疫苗接种专家共识.pdf)])

_儿童变应性鼻炎患者新型冠状病毒疫苗接种专家共识.pdf

下载请点击：

评论区 (9)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1197072, encodeId=5261119e07207, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8826522515, createdName=ms6000001284684199, createdTime=Fri Feb 25 00:48:32 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080272, encodeId=875610802e2ca, content=将疫苗接种与临床医学相结合的复合型人才缺乏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ce6404352, createdName=ms8000000542806281, createdTime=Wed Dec 15 12:19:33 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079305, encodeId=bfab10e9305e1, content=学习！许教授厉害！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fb36399060, createdName=ms3000001304579116, createdTime=Sun Dec 12 19:53:17 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077017, encodeId=4f2510e7017f6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:20:55 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076755, encodeId=a64210e675548, content=谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/6b3718f3d4574c95b1a52760ae70bab8/3d44af5a1d6740738247a19943a382db.jpg, createdBy=8af61701246, createdName=一只没有感情的杀手, createdTime=Sat Dec 04 09:53:08 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
2022-02-25 ms6000001284684199

好

44 0
[GetPortalCommentsPageByObjectIdResponse(id=1197072, encodeId=5261119e07207, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8826522515, createdName=ms6000001284684199, createdTime=Fri Feb 25 00:48:32 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080272, encodeId=875610802e2ca, content=将疫苗接种与临床医学相结合的复合型人才缺乏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ce6404352, createdName=ms8000000542806281, createdTime=Wed Dec 15 12:19:33 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079305, encodeId=bfab10e9305e1, content=学习！许教授厉害！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fb36399060, createdName=ms3000001304579116, createdTime=Sun Dec 12 19:53:17 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077017, encodeId=4f2510e7017f6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:20:55 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076755, encodeId=a64210e675548, content=谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/6b3718f3d4574c95b1a52760ae70bab8/3d44af5a1d6740738247a19943a382db.jpg, createdBy=8af61701246, createdName=一只没有感情的杀手, createdTime=Sat Dec 04 09:53:08 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
2021-12-15 ms8000000542806281

将疫苗接种与临床医学相结合的复合型人才缺乏

59 0
[GetPortalCommentsPageByObjectIdResponse(id=1197072, encodeId=5261119e07207, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8826522515, createdName=ms6000001284684199, createdTime=Fri Feb 25 00:48:32 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080272, encodeId=875610802e2ca, content=将疫苗接种与临床医学相结合的复合型人才缺乏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ce6404352, createdName=ms8000000542806281, createdTime=Wed Dec 15 12:19:33 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079305, encodeId=bfab10e9305e1, content=学习！许教授厉害！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fb36399060, createdName=ms3000001304579116, createdTime=Sun Dec 12 19:53:17 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077017, encodeId=4f2510e7017f6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:20:55 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076755, encodeId=a64210e675548, content=谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/6b3718f3d4574c95b1a52760ae70bab8/3d44af5a1d6740738247a19943a382db.jpg, createdBy=8af61701246, createdName=一只没有感情的杀手, createdTime=Sat Dec 04 09:53:08 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
2021-12-12 ms3000001304579116

学习！许教授厉害！

50 0
[GetPortalCommentsPageByObjectIdResponse(id=1197072, encodeId=5261119e07207, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8826522515, createdName=ms6000001284684199, createdTime=Fri Feb 25 00:48:32 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080272, encodeId=875610802e2ca, content=将疫苗接种与临床医学相结合的复合型人才缺乏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ce6404352, createdName=ms8000000542806281, createdTime=Wed Dec 15 12:19:33 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079305, encodeId=bfab10e9305e1, content=学习！许教授厉害！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fb36399060, createdName=ms3000001304579116, createdTime=Sun Dec 12 19:53:17 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077017, encodeId=4f2510e7017f6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:20:55 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076755, encodeId=a64210e675548, content=谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/6b3718f3d4574c95b1a52760ae70bab8/3d44af5a1d6740738247a19943a382db.jpg, createdBy=8af61701246, createdName=一只没有感情的杀手, createdTime=Sat Dec 04 09:53:08 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
2021-12-05 微探

学习学习

67 0
[GetPortalCommentsPageByObjectIdResponse(id=1197072, encodeId=5261119e07207, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8826522515, createdName=ms6000001284684199, createdTime=Fri Feb 25 00:48:32 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080272, encodeId=875610802e2ca, content=将疫苗接种与临床医学相结合的复合型人才缺乏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ce6404352, createdName=ms8000000542806281, createdTime=Wed Dec 15 12:19:33 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079305, encodeId=bfab10e9305e1, content=学习！许教授厉害！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fb36399060, createdName=ms3000001304579116, createdTime=Sun Dec 12 19:53:17 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077017, encodeId=4f2510e7017f6, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:20:55 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076755, encodeId=a64210e675548, content=谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210510/6b3718f3d4574c95b1a52760ae70bab8/3d44af5a1d6740738247a19943a382db.jpg, createdBy=8af61701246, createdName=一只没有感情的杀手, createdTime=Sat Dec 04 09:53:08 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
2021-12-04 一只没有感情的杀手

谢谢！

58 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

耳鼻咽喉指南

儿童变应性鼻炎患者新型冠状病毒疫苗接种专家共识

相关指南

拓展阅读

科室

工具

服务